Skip to content

Return on equity at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
38.8%+7.3pp
Johnson & Johnson logo
Johnson & JohnsonJNJ
26.4%-3.0pp
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
22.5%+10.1pp
Acadia Pharmaceuticals logo
Acadia PharmaceuticalsACAD
37.3%+0.1pp
AbbVie logo
AbbVieABBV
89%+32.7pp
MeiraGTx Holdings plc logo
MeiraGTx Holdings plcMGTX
-379.5%

Other financials

Income statement

See full
Operating income-$64.5M-174%
Net income-$60.7M-172%
EPS (diluted)-$1.34+95.4%

Balance sheet

See full
Cash & equivalents$55.7M
Total debt$5.6M
Total equity$399.8M+285%
Total assets$418.8M

Cash flow

See full
Operating cash flow-$51.2M-100%
CapEx$24.0K
Free cash flow-$51.2M

Valuation

See full
Market cap$1.39B
Enterprise value$1.34B

Returns & leverage

See full
Debt / equity
Current ratio22.9×